Paganelli Alessia, Didona Dario, Scala Emanuele
Dermatology Unit, IDI-IRCCS Istituto Dermopatico dell'Immacolata, 00167 Rome, Italy.
Rare Diseases Unit, IDI-IRCCS Istituto Dermopatico dell'Immacolata, 00167 Rome, Italy.
Int J Mol Sci. 2025 May 1;26(9):4315. doi: 10.3390/ijms26094315.
Lichen sclerosus (LS) is a chronic inflammatory skin disorder primarily affecting the anogenital region, leading to symptoms such as itching, pain, and sexual dysfunction, all of which significantly impact patients' quality of life. Due to the non-specific nature of its early symptoms, diagnosis is often delayed. This review examines the cytokine networks involved in LS, with a focus on immune activation, the role of T-helper (Th)1 cells, and the interaction between inflammatory mediators and the extracellular matrix, particularly in fibrosis. By providing an updated understanding of LS immunopathogenesis, this review highlights key mediators involved in disease progression and offers insights into personalized treatment strategies that may improve patient outcomes. Additionally, current therapeutic approaches and future directions in LS management are discussed.
硬化性苔藓(LS)是一种主要影响肛门生殖器区域的慢性炎症性皮肤病,会导致瘙痒、疼痛和性功能障碍等症状,所有这些都会显著影响患者的生活质量。由于其早期症状不具有特异性,诊断往往会延迟。本综述研究了参与LS的细胞因子网络,重点关注免疫激活、辅助性T(Th)1细胞的作用以及炎症介质与细胞外基质之间的相互作用,特别是在纤维化方面。通过提供对LS免疫发病机制的最新认识,本综述突出了参与疾病进展的关键介质,并为可能改善患者预后的个性化治疗策略提供了见解。此外,还讨论了LS管理中的当前治疗方法和未来方向。